Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorProtasoni, Margherita
dc.contributor.authorLópez Polo, Vanessa
dc.contributor.authorStephan-Otto Attolini, Camille
dc.contributor.authorHerranz Martín, Nicolás
dc.contributor.authorBrandariz, Julian
dc.contributor.authorMateo, Joaquin
dc.date.accessioned2025-01-28T13:02:26Z
dc.date.available2025-01-28T13:02:26Z
dc.date.issued2024-12-02
dc.identifier.citationProtasoni M, López-Polo V, Stephan-Otto Attolini C, Brandariz J, Herranz N, Mateo J, et al. Cyclophilin D plays a critical role in the survival of senescent cells. EMBO J. 2024 Dec 2;43(23):5972–6000.
dc.identifier.issn1460-2075
dc.identifier.urihttps://hdl.handle.net/11351/12499
dc.descriptionCellular senescence; Cyclophilin D; Mitochondria
dc.description.abstractSenescent cells play a causative role in many diseases, and their elimination is a promising therapeutic strategy. Here, through a genome-wide CRISPR/Cas9 screen, we identify the gene PPIF, encoding the mitochondrial protein cyclophilin D (CypD), as a novel senolytic target. Cyclophilin D promotes the transient opening of the mitochondrial permeability transition pore (mPTP), which serves as a failsafe mechanism for calcium efflux. We show that senescent cells exhibit a high frequency of transient CypD/mPTP opening events, known as 'flickering'. Inhibition of CypD using genetic or pharmacologic tools, including cyclosporin A, leads to the toxic accumulation of mitochondrial Ca2+ and the death of senescent cells. Genetic or pharmacological inhibition of NCLX, another mitochondrial calcium efflux channel, also leads to senolysis, while inhibition of the main Ca2+ influx channel, MCU, prevents senolysis induced by CypD inhibition. We conclude that senescent cells are highly vulnerable to elevated mitochondrial Ca2+ ions, and that transient CypD/mPTP opening is a critical adaptation mechanism for the survival of senescent cells.
dc.language.isoeng
dc.publisherEMBO Press
dc.relation.ispartofseriesThe EMBO Journal;43(23)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMalalties - Tractament
dc.subjectMitocondris
dc.subjectCèl·lules - Envelliment
dc.subject.meshMitochondria
dc.subject.meshCyclophilins
dc.subject.meshCellular Senescence
dc.subject.meshDisease
dc.subject.mesh/drug therapy
dc.titleCyclophilin D plays a critical role in the survival of senescent cells
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s44318-024-00259-2
dc.subject.decsmitocondrias
dc.subject.decsciclofilinas
dc.subject.decssenescencia celular
dc.subject.decsenfermedad
dc.subject.decs/farmacoterapia
dc.relation.publishversionhttps://doi.org/10.1038/s44318-024-00259-2
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Protasoni M] Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Cambridge Institute of Science, Altos Labs, Granta Park, Cambridge, UK. [López-Polo V, Attolini CSO] Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. [Brandariz J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Herranz N] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Mateo J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid39448884
dc.identifier.wos001340282000002
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/CP19%2F00170
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record